Bulk Drugs

Enal Drugs plans expansion programme at Wangapally

Enal Drugs is planning an expansion programme of its plant in Wangapally in Yadagirigutta in Nalagonda district of Telangana. The project involves expanding manufacturing capacity of active pharmaceutical ingredients from 966 tpa to 1800 tpa. The project cost is estimated at Rs. 400 million. After expansion, the plant will produce Lansoprazole, Rabeprazole Sodium, Zalepon, Omeprazole and other anti ulcerative drug intermediates.
Read More

Telangana to unveil new Pharma policy

Telangana government is ready to unveil a draft new policy on Pharma and Bulk Drug Sector. The state government has acquired 11,000 acres of land at Mucherla at the outskirts of Hyderabad . (roughly 70 kms away ) They are in the process of preparing a detailed project report (DPR) in coordination with the pharma industry and the pollution control board so that every ingredient required for the industry and environment safety is incorporated. With the ?Make in India policy? of the government, the industry is expecting sops like tax breaks, weighted tax deduction at 150 per cent for R&D expenditure and availability of affordable land for the industry. Already, Hyderabad has a strong base for bulk drug industries in India contributing one third of country?s bulk drug production. Taking t
Read More


  • No Image
    Mylan Pharmaceuticals Pvt Ltd

    Mylan Pharma is a world?s leading pharmaceutical company with a significant and growing presence in India. Its history in India began in 2007 with the acquisition of Matrix Lab

  • No Image
    Nakoda Chemical Ltd

    Nakoda Chemicals Ltd is a manufacturer of Bulk Active Pharmaceutical Ingredients (APIs), Intermediates, Specialty Chemicals and Custom Synthesis Products. Incorporated in the Y